Can serum estradiol levels on the fourth day of IVF/ICSI cycle predict outcome in poor responder women?

References

• Bentov, Y., Burstein, E., Firestone, C., Firestone, R., Esfandiari, N., and Casper, R.F. (2013) Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization? Reprod Biol Endocrinol 11:12. doi: 10.1186/1477-7827-11-12. PubMed PMID: 23433095; PubMed Central PMCID: PMC3607851
   PubMed Web of Science ®Google Scholar
• Eftekhar, M., Aflatoonian, A., Mohammadian, F., and Eftekhar, T. (2013) Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet 287:1017–21
   PubMed Web of Science ®Google Scholar
• Ferraretti, A.P., La Marca, A., Fauser, B.C., Tarlatzis, B., Nargund, G., Gianaroli, L., et al. (2011) ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum Reprod 26:1616–24
   PubMed Web of Science ®Google Scholar
• Fouany, M.R., Sharara, F.I. (2013) Is there a role for DHEA supplementation in women with diminished ovarian reserve? J Assist Reprod Genet 30:1239–44
   PubMed Web of Science ®Google Scholar
• Fusi, F.M., Ferrario, M., Bosisio, C., Arnoldi, M., and Zanga, L. (2013) DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function. Gynecol Endocrinol 29:940–3
   PubMed Web of Science ®Google Scholar
• Koshy, A.K., Gudi, A., Shah, A., Bhide, P., Timms, P., and Homburg, R. (2013) Pregnancy prognosis in women with anti-Mullerian hormone below the tenth percentile. Gynecol Endocrinol 29:662–5
   PubMed Web of Science ®Google Scholar
• Muasher, S.J., Oehninger, S., Simonetti, S., Matta, J., Ellis, L.M., Liu, H.C., et al. (1988) The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50:298–307
   PubMed Web of Science ®Google Scholar
• Mutlu, M.F., Erdem, M., Erdem, A., Yildiz, S., Mutlu, I., Arisoy, O., et al. (2013) Antral follicle count determines poor ovarian response better than anti-Mullerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet 30:657–65
   PubMed Web of Science ®Google Scholar
• Narkwichean, A., Maalouf, W., Campbell, B.K., and Jayaprakasan, K. (2013) Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: A meta-analysis. Reprod Biol Endocrinol 11:44. doi: 10.1186/1477-7827-11-44. Review. PubMed PMID: 23680224; PubMed Central PMCID: PMC3663765
   PubMed Web of Science ®Google Scholar
• Oudendijk, J.F., Yarde, F., Eijkemans, M.J., Broekmans, F.J., and Broer, S.L. (2012) The poor responder in IVF: Is the prognosis always poor?: A systematic review. Hum Reprod Update 18:1–11
   PubMed Web of Science ®Google Scholar
• Satwik, R., Kochhar, M., Gupta, S.M., and Majumdar, A. (2012) Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization. J Hum Reprod Sci 5:206–12
   PubMedGoogle Scholar
• Singh, N., Zangmo, R., Kumar, S., Roy, K.K., Sharma, J.B., Malhotra, N., et al. (2013) A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve. Gynecol Endocrinol 29:989–92
   PubMed Web of Science ®Google Scholar
• Smotrich, D.B., Widra, E.A., Gindoff, P.R., Levy, M.J., Hall, J.L., and Stillman, R.J. (1995) Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64:1136–40
   PubMed Web of Science ®Google Scholar
• Somigliana, E., Paffoni, A., Busnelli, A., Cardellicchio, L., Leonardi, M., Filippi, F., et al. (2013) IVF outcome in poor responders failing to produce viable embryos in the preceding cycle. Reprod Biomed Online 26:569–76
   PubMed Web of Science ®Google Scholar
• Watt, A.H., Legedza, A.T., Ginsburg, E.S., Barbieri, R.L., Clarke, R.N., and Hornstein, M.D. (2000) The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization. J Assist Reprod Genet 17:264–8
   PubMed Web of Science ®Google Scholar
• Yang, S.H., Patrizio, P., Yoon, S.H., Lim, J.H., and Chian, R.C. (2012) Comparison of pregnancy outcomes in natural cycle IVF/M treatment with or without mature oocytes retrieved at time of egg collection. Syst Biol Reprod Med 58:154–9
   PubMed Web of Science ®Google Scholar
• Yilmaz, N., Uygur, D., Inal, H., Gorkem, U., Cicek, N., and Mollamahmutoglu, L. (2013) Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: Serum AMH, inhibin B and antral follicle count. Eur J Obstet Gynecol Reprod Biol 169:257–60
   PubMed Web of Science ®Google Scholar